Free Trial

Natural Alternatives International (NAII) Competitors

Natural Alternatives International logo
$2.74 0.00 (-0.18%)
As of 04/17/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NAII vs. CRBU, XCUR, EPIX, UNCY, SGMT, ADAG, ADVM, IGMS, LXEO, and CRBP

Should you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Caribou Biosciences (CRBU), Exicure (XCUR), ESSA Pharma (EPIX), Unicycive Therapeutics (UNCY), Sagimet Biosciences (SGMT), Adagene (ADAG), Adverum Biotechnologies (ADVM), IGM Biosciences (IGMS), Lexeo Therapeutics (LXEO), and Corbus Pharmaceuticals (CRBP). These companies are all part of the "pharmaceutical products" industry.

Natural Alternatives International vs.

Caribou Biosciences (NASDAQ:CRBU) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk.

Natural Alternatives International received 249 more outperform votes than Caribou Biosciences when rated by MarketBeat users. Likewise, 76.82% of users gave Natural Alternatives International an outperform vote while only 61.90% of users gave Caribou Biosciences an outperform vote.

CompanyUnderperformOutperform
Caribou BiosciencesOutperform Votes
26
61.90%
Underperform Votes
16
38.10%
Natural Alternatives InternationalOutperform Votes
275
76.82%
Underperform Votes
83
23.18%

Natural Alternatives International has a net margin of -6.26% compared to Caribou Biosciences' net margin of -1,290.81%. Natural Alternatives International's return on equity of -9.36% beat Caribou Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Caribou Biosciences-1,290.81% -45.46% -38.07%
Natural Alternatives International -6.26%-9.36%-4.82%

77.5% of Caribou Biosciences shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 9.5% of Caribou Biosciences shares are owned by insiders. Comparatively, 20.9% of Natural Alternatives International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Caribou Biosciences had 6 more articles in the media than Natural Alternatives International. MarketBeat recorded 9 mentions for Caribou Biosciences and 3 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 0.33 beat Caribou Biosciences' score of 0.22 indicating that Natural Alternatives International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Caribou Biosciences
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Natural Alternatives International
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Caribou Biosciences has a beta of 2.36, indicating that its share price is 136% more volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Natural Alternatives International has higher revenue and earnings than Caribou Biosciences. Natural Alternatives International is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Caribou Biosciences$9.99M6.84-$102.07M-$1.65-0.45
Natural Alternatives International$121.85M0.14-$7.22M-$1.29-2.09

Caribou Biosciences currently has a consensus price target of $10.33, indicating a potential upside of 1,305.90%. Given Caribou Biosciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Caribou Biosciences is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Caribou Biosciences
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Natural Alternatives International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Natural Alternatives International beats Caribou Biosciences on 10 of the 18 factors compared between the two stocks.

Get Natural Alternatives International News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAII vs. The Competition

MetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$16.68M$1.18B$5.31B$7.35B
Dividend YieldN/AN/A5.45%4.31%
P/E Ratio-2.0910.0421.9417.82
Price / Sales0.149.44380.9497.68
Price / CashN/A10.4038.2634.64
Price / Book0.211.216.453.98
Net Income-$7.22M-$56.07M$3.22B$247.81M
7 Day Performance-7.72%5.88%5.85%3.19%
1 Month Performance-25.59%-8.03%-9.55%-7.70%
1 Year Performance-59.73%-40.03%11.83%1.49%

Natural Alternatives International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
1.2491 of 5 stars
$2.69
-2.2%
N/A-59.7%$16.68M$121.85M-2.09290Analyst Forecast
Short Interest ↓
News Coverage
Gap Up
High Trading Volume
CRBU
Caribou Biosciences
2.3736 of 5 stars
$0.80
-8.5%
$10.33
+1,191.3%
-80.9%$74.42M$9.99M-0.48100Analyst Revision
News Coverage
XCUR
Exicure
2.0296 of 5 stars
$11.73
+1.3%
N/A+1,404.5%$74.11M$500,000.00-5.6750Short Interest ↓
News Coverage
Gap Up
EPIX
ESSA Pharma
2.5724 of 5 stars
$1.65
+4.4%
$9.50
+475.8%
-71.7%$73.24MN/A-2.3950
UNCY
Unicycive Therapeutics
2.6897 of 5 stars
$0.61
+11.4%
$5.25
+760.7%
-43.9%$73.02M$680,000.00-0.639
SGMT
Sagimet Biosciences
2.1224 of 5 stars
$2.38
+3.0%
$22.40
+841.2%
-44.9%$73.01M$2M-1.668Gap Up
ADAG
Adagene
2.3738 of 5 stars
$1.52
-0.7%
$8.00
+426.3%
-42.0%$72.08M$103,204.000.00260Short Interest ↑
Gap Up
ADVM
Adverum Biotechnologies
3.7029 of 5 stars
$3.43
flat
$27.83
+711.5%
-74.2%$71.35M$1M-0.57190Earnings Report
Analyst Forecast
News Coverage
IGMS
IGM Biosciences
3.1016 of 5 stars
$1.19
-0.8%
$5.50
+362.2%
-83.1%$71.13M$2.68M-0.33190News Coverage
LXEO
Lexeo Therapeutics
3.0349 of 5 stars
$2.14
+8.1%
$22.20
+937.4%
-77.5%$71.04M$650,000.00-0.6858
CRBP
Corbus Pharmaceuticals
3.1189 of 5 stars
$5.80
-4.0%
$59.13
+919.4%
-84.6%$70.95MN/A-1.2440News Coverage

Related Companies and Tools


This page (NASDAQ:NAII) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners